Bin Sun
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in ⓘ
- Hepatology 14
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Liver physiology and pathology 7
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 8
- Co-authors
- Changqing Su (17 shared papers)Weidan Ji (11 shared papers)Xiaofeng Zhang (12 shared papers)Zhengfeng Yin (12 shared papers)Haihua Qian (11 shared papers)Mengchao Wu (8 shared papers)Yang Xu (3 shared papers)Quangen Gao (1 shared paper)
- Journals
- PLoS ONE (7 papers)Cancer Letters (6 papers)Oncotarget (5 papers)Clinical Infectious Diseases (2 papers)OncoTargets and Therapy (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bin Sun
94 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Cancer Research 729
- Hepatology 281
- Oncology 707
- Gastroenterology 107
- Infectious Diseases 357
Countries citing papers authored by Bin Sun
This map shows the geographic impact of Bin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Sun more than expected).
Fields of papers citing papers by Bin Sun
This network shows the impact of papers produced by Bin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Sun. The network helps show where Bin Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility Hit paper breakdown → | 2020 | 355 |
| 2 | 2014 | 189 | |
| 3 | 2013 | 155 | |
| 4 | 2017 | 142 | |
| 5 | 2004 | 135 | |
| 6 | 2007 | 106 | |
| 7 | 2014 | 101 | |
| 8 | 2015 | 80 | |
| 9 | 2019 | 69 | |
| 10 | 2014 | 67 | |
| 11 | 2008 | 66 | |
| 12 | 2019 | 65 | |
| 13 | 2018 | 65 | |
| 14 | 2016 | 58 | |
| 15 | 2014 | 57 | |
| 16 | 2014 | 57 | |
| 17 | 2017 | 54 | |
| 18 | 2012 | 49 | |
| 19 | 2019 | 49 | |
| 20 | 2017 | 49 |
About Bin Sun
Bin Sun is a scholar working on Hepatology, Cancer Research, Oncology, Otorhinolaryngology and Cell Biology, having authored 94 papers that have together received 3.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers), Liver physiology and pathology (7 papers), Circular RNAs in diseases (7 papers), RNA modifications and cancer (7 papers), Cancer Cells and Metastasis (7 papers) and Cancer Mechanisms and Therapy (6 papers). The work is most often cited by research in Cancer Research (729 citations), Hepatology (281 citations), Oncology (707 citations), Gastroenterology (107 citations) and Infectious Diseases (357 citations). Bin Sun has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Changqing Su, Weidan Ji, Xiaofeng Zhang, Zhengfeng Yin, Haihua Qian, Mengchao Wu, Yang Xu, Quangen Gao, Xiaoya Li and Yan Liu. Their work appears in journals such as PLoS ONE, Cancer Letters, Oncotarget, Clinical Infectious Diseases and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.